Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Assisted Reproduction and Genetics
Published in: Journal of Assisted Reproduction and Genetics 7/2018

01-07-2018 | Assisted Reproduction Technologies

Compensating human subjects providing oocytes for stem cell research: 9-year experience and outcomes

Authors: L. Zakarin Safier, A. Gumer, M. Kline, D. Egli, M. V. Sauer

Published in: Journal of Assisted Reproduction and Genetics | Issue 7/2018

Login to get access

Abstract

Purpose

Human oocytes are arguably one of the most important cell types in humans, yet they are one of the least investigated cells. Because oocytes are limited in number, the use of high-quality oocytes is almost entirely in reproduction. Furthermore, regulatory hurdles for research on gametes and regulations on funding related to research on gametes present significant obstacles to research and the advancement of reproductive treatments. Here we report the outcomes of the largest compensated oocyte donation program for research in the USA to date, and probably worldwide.

Methods

Women who participated in oocyte donation for research between 2008 and 2017 were contacted in a phone interview and completed a standardized questionnaire.

Results

Of 114 participants, 98 oocyte donors completed donation, donating 1787 mature MII oocytes and a total of 86 skin biopsies. Complication rate, including minor complications, of oocyte donation was 8/98, or 8.1%, for which two involved follow-up. Fifty-seven donors answered questions about their experience. Participants were incentivized primarily by money and a desire to help others and reported an overall favorable experience. Most, but not all, human subjects recalled that they had donated for research, and approximately half recalled that their oocytes were being used specifically for stem cell research.

Conclusions

Compensated oocyte donation provides a reliable path to obtaining high-quality oocytes for research and is reviewed favorably by oocyte donors. The continuation of programs that offer compensation for oocyte donation is invaluable to continued progress and advancements in stem cell research and human embryology, and for the advancement of novel reproductive treatments.
Literature
1.
2008 Guidelines for gamete and embryo donation: a Practice Committee report. Fertility and sterility 90, S30–44.
2.
Board, E.S.S.C. Statement of the Empire State Stem Cell Board on the Compensation of Oocyte Donors (NY.Gov).
3.
Carson SA, Eschenbach DA, Lomax G, Rice VM, Sauer MV, Taylor RN. Proposed oocyte donation guidelines for stem cell research. Fertil Steril. 2010;94:2503–6.CrossRefPubMed
4.
Chia G, Agudo J, Treff N, Sauer MV, Billing D, Brown BD, et al. Genomic instability during reprogramming by nuclear transfer is DNA replication dependent. Nat Cell Biol. 2017;19:282–91.CrossRefPubMedPubMedCentral
5.
Chia G, Egli D. Connecting the cell cycle with cellular identity. Cell Reprogram. 2013;15:356–66.CrossRefPubMed
6.
Congress, t. H.R.2880—Balanced Budget Downpayment Act. In: I; 1995.
7.
Egli D, Chen AE, Saphier G, Powers D, Alper M, Katz K, et al. Impracticality of egg donor recruitment in the absence of compensation. Cell Stem Cell. 2011;9:293–4.CrossRefPubMed
8.
Ethics, A.C.o. ACOG Committee Opinion No. 347, November 2006: Using preimplantation embryos for research. Obstet Gynecol. 2006;108:1305–17.CrossRef
9.
Harmon K. For sale: human eggs become a research commodity. In Scientific American. 2009.
10.
Hiltzik M. Should we pay women to donate their eggs for research? No, and here’s why. In Los Angeles Times. 2016.
11.
Hynes RO, Moreno JD, Price Foley E, Fost N, Horvitz HR, Imbrescia M, et al. Guidelines for human embryonic stem cell research. Washington, D.C.: The National Academies Press; 2005.
12.
Hyslop LA, Blakeley P, Craven L, Richardson J, Fogarty NM, Fragouli E, et al. Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease. In: Nature, vol. 534; 2016. p. 383–6.
13.
14.
ISSCR (2007). Guidelines for the conduct of human embryonic stem cell research. Curr Protoc Stem Cell Biol Appendix 1, Appendix 1A.
15.
Johannesson B, Sagi I, Gore A, Paull D, Yamada M, Golav-Lev T, LeDuc C, Shen Y, Stern S, Xu N, et al. Comparable frequencies of coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors. Cell stem cell in press. 2014
16.
17.
Knaub K. Egg donors get pay limits axed with antitrust settlement, law360, ed. 2016
18.
Kort DH, Chia G, Treff NR, Tanaka AJ, Xing T, Vensand LB, et al. Human embryos commonly form abnormal nuclei during development: a mechanism of DNA damage, embryonic aneuploidy, and developmental arrest. In: Human reproduction. Oxford: England; 2015. p. dev281.
19.
LEGISLATURE, C. ( ). California code, health and safety code. In HSC § 125355.
20.
Liang P, Xu Y, Zhang X, Ding C, Huang R, Zhang Z, et al. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein & cell. 2015;6:363–72.CrossRef
21.
Ma H, O'Neil RC, Marti Gutierrez N, Hariharan M, Zhang ZZ, He Y, et al. Functional human oocytes generated by transfer of polar body genomes. In: Cell stem cell; 2016.
22.
Medicine ECOTASFR. Financial compensation of oocyte donors. Fertil Steril. 2007;88:305–9.CrossRef
23.
Noggle S, Fung HL, Gore A, Martinez H, Satriani KC, Prosser R, et al. Human oocytes reprogram somatic cells to a pluripotent state. Nature. 2011;478:70–5.CrossRefPubMed
24.
Panel HER. N.I.o. Health, ed. Bethesda, MD: NIH; 1994.
25.
Paull D, Emmanuele V, Weiss KA, Treff N, Stewart L, Hua H, et al. Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants. Nature. 2013;493:632–7.CrossRefPubMed
26.
Roxland BE. New York State’s landmark policies on oversight and compensation for egg donation to stem cell research. Regen Med. 2012;7:397–408.CrossRefPubMed
27.
Sagi I, Chia G, Golan-Lev T, Peretz M, Weissbein U, Sui L, et al. Derivation and differentiation of haploid human embryonic stem cells. Nature. 2016;532:107–11.CrossRefPubMed
28.
29.
Steinbock B. Payment for egg donation and surrogacy. The Mount Sinai journal of medicine, New York. 2004;71:255–65.PubMed
30.
31.
Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner-Hedges R, Ma H, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013a;153:1228–38.CrossRefPubMedPubMedCentral
32.
Tachibana M, Amato P, Sparman M, Woodward J, Sanchis DM, Ma H, et al. Towards germline gene therapy of inherited mitochondrial diseases. Nature. 2013b;493:627–31.CrossRefPubMed
33.
Yamada M, Emmanuele V, Sanchez-Quintero MJ, Sun B, Lallos G, Paull D, et al. Genetic drift can compromise mitochondrial replacement by nuclear transfer in human oocytes. Cell Stem Cell. 2016;18:749–54.CrossRefPubMed
34.
Yamada M, Johannesson B, Sagi I, Burnett LC, Kort DH, Prosser RW, et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature. 2014;510:533–6.CrossRefPubMed
Metadata
Title
Compensating human subjects providing oocytes for stem cell research: 9-year experience and outcomes
Authors
L. Zakarin Safier
A. Gumer
M. Kline
D. Egli
M. V. Sauer
Publication date
01-07-2018
Publisher
Springer US
Published in
Journal of Assisted Reproduction and Genetics / Issue 7/2018
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-018-1171-z

Other articles of this Issue 7/2018

Journal of Assisted Reproduction and Genetics 7/2018 Go to the issue

Assisted Reproduction Technologies

The influence of body mass index on pregnancy outcome following single-embryo transfer

Assisted Reproduction Technologies

Vitamin D as a follicular marker of human oocyte quality and a serum marker of in vitro fertilization outcome

Commentary

Lack of reproducibility in oocyte vitrification calls for a simpler (whether semi-manual or automatic) and standardized methodology

Assisted Reproduction Technologies

Effect of pre-gravid body mass index on outcomes of pregnancies following in vitro fertilization

Review

Biomechanics and mechanical signaling in the ovary: a systematic review

Genetics

A novel mutation in the TUBB8 gene is associated with complete cleavage failure in fertilized eggs